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In this issue, Joel publishes a thoughtful iteration of
the circuit models that have dominated thinking about
basal ganglia pathophysiology for almost 15 years.1–4
These models have generally been fruitful in the sense
that they have led to new experiments, and somewhat
surprisingly, provided support and guidance for novel
therapeutic approaches. For example, these models all
emphasized the importance of the subthalamic nucleus as
a key regulator of basal ganglia output, and provided a
good deal of impetus for the implementation of pal-
lidotomy and subthalamic deep brain stimulation as
treatments for parkinsonism. The relative success of
these models is surprising in view of the fact that they are
simple anatomic constructs with little effort to incorpo-
rate anything beyond the crudest notions of physiology.
Many aspects of these models have been challenged ap-
propriately. As Joel makes clear, the anatomy of the
basal ganglia is much more complicated than the original
versions of these models present. In particular, Joel takes
pains to incorporate advances in knowledge of striatal
output pathways that add new dimensions of complexity
to basal ganglia circuitry. While the original models in-
corporated the idea of “closed” cortico-basal ganglionic-
thalamocortical loops and had simple definitions of the
so-called direct and indirect pathways, Joel and others
emphasize the interconnection between these circuits.5–7
This approach has the virtue, explicated rigorously by
Joel, of allowing relatively discrete lesions to have con-
sequences that ramify beyond the major function of the
circuit primarily affected. In Joel’s construct, many phe-
nomena associated with Huntington disease can be ex-
plained by pathology in the associative portions of the
striatum. Joel also points out some predictions of the
model that can be evaluated experimentally, a necessary
feature of any good model.
Joel’s model preserves one of the strongest and worst
features of the original models. These models are not
physiologically based, but are rather elaborate examples
of clinico-pathologic correlation. This is a strong method
for attempting to understand the basis of clinical phe-
nomena and has real power in assisting the development
of new therapies. This method is limited ultimately by
how much physiological meaning we can extract from
studying clinical phenomena. An instructive comparison
is the study of perception. In terms of really understand-
ing brain function, it seems that study of perceptual pro-
cesses, particularly visual perception, is farther advanced
than any other area of neuroscience. Perceptual neuro-
scientists benefit from substantial advantages. Unlike
motor physiologists, sensory physiologists can correlate
neural activity with precisely defined inputs. These in-
puts can be decomposed into well-understood physical
properties, and the distinguished tradition of psycho-
physics provides useful measurement tools. These tools
can be applied to human experiments, animal experi-
ments, and more recently, functional imaging experi-
ments. Very little work on basal ganglia function can
claim the relative success of sensory physiology in giv-
ing mechanistic accounts of sensory, particularly visual,
function. Models of basal ganglia pathophysiology are
formulated in the absence of good understanding of nor-
mal basal ganglia function(s).
Joel’s model pushes the clinical correlation method to
its limits. She makes a number of associations between
specific deficits in Huntington disease subjects and spec-
ulated dysfunctions within defined pathways. These as-
sociations, however, are based on constructs with rela-
tively shaky foundations. She incorporates well, for ex-
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ample, the popular idea that the basal ganglia are
involved in regulating motor programs. But what is the
actual evidence for this idea? What type of experiments
would one do to falsify both the general idea and Joel’s
specific version of this concept? Without better under-
standing of normal basal ganglia function(s), there is a
real danger that the articulation of these models could
become an end in itself. As long as these models lead to
interesting experiments, they are useful. Joel, to her
credit, suggests some interesting experiments that derive
from this model. Mink attempted to recast these models
in more concretely physiological terms and suggested
other potentially useful experimental approaches.8 We
need, however, better neurophysiology of normal basal
ganglia function(s) to understand disease processes. Oth-
erwise, there is danger that we could end up like medi-
eval Ptolemaic astronomers, endlessly adding epicycles
to our model in order to “save the phenomena.”
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